These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26329152)

  • 1. [Sialic Acid Replacement Therapy for Distal Myopathy with Rimmed Vacuoles].
    Mori-Yoshimura M; Nishino I
    Brain Nerve; 2015 Sep; 67(9):1115-23. PubMed ID: 26329152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of Aceneuramic Acid for Distal Myopathy with Rimmed Vacuoles].
    Aoki M; Izumi R; Suzuki N
    Brain Nerve; 2023 Oct; 75(10):1149-1154. PubMed ID: 37849366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
    Malicdan MC; Noguchi S; Nonaka I; Hayashi YK; Nishino I
    Hum Mol Genet; 2007 Nov; 16(22):2669-82. PubMed ID: 17704511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sialic Acid supplementation therapy for distal myopathy with rimmed vacuoles].
    Nishino I; Noguchi S
    Brain Nerve; 2012 Mar; 64(3):255-61. PubMed ID: 22402719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Gne knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
    Malicdan MC; Noguchi S; Nonaka I; Hayashi YK; Nishino I
    Hum Mol Genet; 2007 Jan; 16(2):115-28. PubMed ID: 17164266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic development for GNE myopathy.].
    Suzuki N; Izumi R; Kato M; Warita H; Aoki M
    Clin Calcium; 2017; 27(3):429-434. PubMed ID: 28232658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice.
    Yonekawa T; Malicdan MC; Cho A; Hayashi YK; Nonaka I; Mine T; Yamamoto T; Nishino I; Noguchi S
    Brain; 2014 Oct; 137(Pt 10):2670-9. PubMed ID: 25062695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GNE myopathy].
    Urtizberea JA; Béhin A
    Med Sci (Paris); 2015 Nov; 31 Spec No 3():20-7. PubMed ID: 26546927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distal myopathy with rimmed vacuoles and inflammation: a genetically proven case.
    Kannan MA; Challa S; Urtizberea AJ; Krahn M; Jabeen AS; Borgohain R
    Neurol India; 2012; 60(6):631-4. PubMed ID: 23287327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy: contributions from an animal model. Lack of sialic acid, a central determinant in sugar chains, causes myopathy?
    Malicdan MC; Noguchi S; Nishino I
    Acta Myol; 2007 Dec; 26(3):171-5. PubMed ID: 18646567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and clinical efficacy of 6'-sialyllactose in patients with GNE myopathy: Randomized pilot trial.
    Park YE; Park E; Choi J; Go H; Park DB; Kim MY; Sung NJ; Kim L; Shin JH
    Biomed Pharmacother; 2023 Dec; 168():115689. PubMed ID: 37852099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GNE myopathy: from clinics and genetics to pathology and research strategies.
    Pogoryelova O; González Coraspe JA; Nikolenko N; Lochmüller H; Roos A
    Orphanet J Rare Dis; 2018 May; 13(1):70. PubMed ID: 29720219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of therapy for distal myopathy with rimmed vacuoles].
    Nishino I; Malicdan MC; Noguchi S
    Rinsho Shinkeigaku; 2009 Nov; 49(11):852-5. PubMed ID: 20030229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sialic acid supplementation therapy for distal myopathy with rimmed vacuoles (GNE myopathy)].
    Nishino I; Noguchi S
    Rinsho Shinkeigaku; 2012; 52(11):1210-2. PubMed ID: 23196566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathomechanism of distal myopathy with rimmed vacuoles.
    Nishino I; Malicdan MC; Murayama K; Nonaka I; Hayashi YK; Noguchi S
    Acta Myol; 2005 Oct; 24(2):80-3. PubMed ID: 16550921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Animal model of distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy and preclinical trial with sugar compounds].
    Noguchi S; Malicdan MC; Nishino I
    Brain Nerve; 2010 Jun; 62(6):601-7. PubMed ID: 20548120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation profile of the GNE gene in Japanese patients with distal myopathy with rimmed vacuoles (GNE myopathy).
    Cho A; Hayashi YK; Monma K; Oya Y; Noguchi S; Nonaka I; Nishino I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):914-7. PubMed ID: 24027297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding pathophysiology of GNE myopathy and current progress towards drug development.
    Mashangva F; Singh S; Oswalia J; Arya R
    J Biosci; 2024; 49():. PubMed ID: 38383974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of DMRV/hIBM.
    Malicdan MC; Noguchi S; Hayashi YK; Nishino I
    Physiol Genomics; 2008 Sep; 35(1):106-15. PubMed ID: 18628337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular pathomechanism of distal myopathy with rimmed vacuoles].
    Nishino I; Noguchi S; Murayama K; Ohkuma A; Kasahata N; Malicdan MC; Hayashi YK; Nonaka I
    Rinsho Shinkeigaku; 2005 Nov; 45(11):943-5. PubMed ID: 16447769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.